Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03648424 · ClinicalTrials.gov registry record
Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 48,262
- Enrollment target
NCT03648424: Completed study, sponsored by Brigham and Women's Hospital.
NCT03648424 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 48,262 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03648424 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 48,262 participants
- Enrollment target
Study Summary
This cohort study was initiated to predict the findings of CAROLINA trial in a real world setting using electronic claims data from insurance databases with results anticipated prior to the completion of CAROLINA.
Primary Outcome
Composite CV Outcome includes Myocardial infarction, Stroke, hospitalization for unstable angina and Death
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48,262 participants |
| Start Date | 2011-05-01 |
| Est. Completion | 2019-06-01 |
What the finished NCT03648424 record still lists
NCT03648424 is an observational study that tracks outcomes without assigning an intervention. Its 48,262 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03648424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03648424 about?
NCT03648424 is a clinical study titled "Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses". This cohort study was initiated to predict the findings of CAROLINA trial in a real world setting using electronic claims data from insurance databases with results anticipated prior to the completion of CAROLINA.
What is the current status of trial NCT03648424?
This trial is currently completed. The enrollment target is 48,262 participants. The study started on 2011-05-01. Estimated completion is 2019-06-01.
Who is sponsoring clinical trial NCT03648424?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06655974 · 48,000 participants · NA
Predictive Modeling for Social Needs in Emergency Department Settings
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI